July 20, 2011 โ€” IDEV Technologies Inc. announced the completion of enrollment in the SUPERB trial, a U.S. Food and Drug Administration (FDA)-approved IDE trial evaluating the use of IDEV's Supera stent system for treatment of peripheral artery disease (PAD) in the superficial femoral artery (SFA). Enrollment was completed in May, making SUPERB one of the fastest-enrolling SFA trials.

July 20, 2011 โ€” Ziehm Imaging reports a huge increase in demand for its training programs. In 2010 alone, the number of participants doubled for technical courses given by the mobile C-arm manufacturer.

July 19, 2011 โ€” Terumo Heart Inc., a wholly owned subsidiary of Terumo Corp., today announced that a patient implanted with the DuraHeart left ventricular assist system (LVAS) has surpassed five years of support on the mechanical circulatory support device. Helga Gieseke, living in Germany, was treated at The Deutsches Herzzentrum Berlin (DHZB, German Heart Institute Berlin) and is now one of the longest-living heart failure recipients of the DuraHeart LVAS device.

July 19, 2011 โ€” An article published in the July issue of the Journal of Heart and Lung Transplantation reports the first use of the Freedom portable driver with a Total Artificial Heart (TAH-t) patient. The TAH-t is manufactured by SynCardia Systems Inc.

July 19, 2011 - The Society of Cardiovascular Computed Tomography (SCCT) announces the first SCCT Arthur S. Agatston Cardiovascular Disease Prevention Award, recognizing individuals whose pioneering efforts have saved lives from coronary artery disease (CAD). Arthur Agatston, M.D., presented the award to the first recipients at the SCCT annual scientific meeting in Denver, Colo., on Saturday, July 16, 2011.

July 18, 2011 โ€” NSVascular Inc., a newly formed subsidiary of NeuroSigma Inc., has signed an exclusive license with the University of California Los Angeles (UCLA) covering its medical applications of thin-film nitinol (TFN) technology.

July 18, 2011 โ€” OrbusNeich announced that data from an ex vivo arteriovenous (AV) shunt model of human circulating blood, in addition to results from three preclinical studies, demonstrated that the Genous Stent effectively captures circulating CD34+ endothelial progenitor cells (EPCs). This leads to accelerated re-endothelialization and decreased thrombogenicity compared to bare metal stents (BMS). These mechanistic data were published as an e-publication on the European Heart Journal website.

July 18, 2011 โ€” An article published in the European Journal of Cardio-Thoracic Surgery demonstrates the importance of a comprehensive epicardial lesion pattern to confirm conduction block in radiofrequency ablation for the successful treatment of persistent atrial fibrillation (AF). The epicardial ablation device is manufactured by nContact Inc.

July 15, 2011 โ€” TeraRecon Inc. will highlight the accessibility and clinical workflow impact of its iNtuition solution at the sixth annual scientific meeting of the Society of Cardiovascular Computed Tomography (SCCT) at the Hyatt Regency Denver at Colorado Convention Center in Denver, Colo., July 14-17, 2011.

Subscribe to
ยฉ Copyright Wainscot Media. All Rights Reserved.
Subscribe Now